Sonark Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 29-11-2024
- Paid Up Capital ₹ 4.00 M
as on 29-11-2024
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 M
as on 29-11-2024
- Revenue -7.01%
(FY 2023)
- Profit 407.53%
(FY 2023)
- Ebitda -16.18%
(FY 2023)
- Net Worth 11.27%
(FY 2023)
- Total Assets 14.45%
(FY 2023)
About Sonark Pharmaceutical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹7.50 M.
Girish Soman, Jalindar Shinde, Devendra Soman, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24232MH1988PTC049307
- Company No.
049307
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sonark Pharmaceutical?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Soman  | Director | 14-Dec-2009 | Current |
| Devendra Soman | Director | 23-Feb-2022 | Current |
| Jalindar Shinde | Director | 14-Dec-2009 | Current |
| Tanmay Soman | Director | 23-Feb-2022 | Current |
| Shantanu Shinde | Director | 23-Feb-2022 | Current |
| Arati Soman | Director | 29-Sep-2023 | Current |
Financial Performance of Sonark Pharmaceutical.
Sonark Pharmaceutical Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.01% decrease. The company also saw a substantial improvement in profitability, with a 407.53% increase in profit. The company's net worth Soared by an impressive increase of 11.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sonark Pharmaceutical?
Unlock access to Sonark Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nisarga Healthcare Private LimitedActive 16 years 8 monthsGirish Soman, Jalindar Shinde and 2 more are mutual person
Nisarga Biotech Private LimitedActive 26 years 10 monthsGirish Soman, Jalindar Shinde and 5 more are mutual person
Sanvardhini Agro Pvt LtdActive 31 years 7 monthsGirish Soman, Jalindar Shinde and 3 more are mutual person
- Krushitek Private LimitedActive 24 years 6 months
Girish Soman, Jalindar Shinde and 3 more are mutual person
Charges (Loans)
₹7.50 M
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2015 | Idbi Bank Limited | ₹1.70 M | Open |
| 04 Sep 2010 | Idbi Bank Limited | ₹5.80 M | Open |
How Many Employees Work at Sonark Pharmaceutical?
Sonark Pharmaceutical has a workforce of 15 employees as of Nov 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sonark Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sonark Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
